E-LIB Suche - Ergebnisse für: Londono, S.

1

EE9 Economic Burden of Gaucher Disease in Colombia:

Upegui, Pachon A ; Mora, L ; Romero, M...
Value in Health. 27 (2024) 6 - p. S58 , 2024

Link: https://doi.org/10.1016/..

2

EE120 Economic Burden of Pompe Disease in Colombia:

Upegui, Pachon A ; Chacon, C ; Salgado, S...
Value in Health. 27 (2024) 6 - p. S79 , 2024

Link: https://doi.org/10.1016/..

3

EE316 Economic Burden of Fabry Disease in Colombia:

Upegui, Pachon A ; Becerra, J ; Salgado, S...
Value in Health. 27 (2024) 6 - p. S115 , 2024

Link: https://doi.org/10.1016/..

4

EE621 Cost-Effectiveness Analysis of iGlarLixi Compared Wit..:

Londono, S. ; Garcia, W. ; Salamanca, C....
Value in Health. 26 (2023) 12 - p. S172 , 2023

Link: https://doi.org/10.1016/..

5

CO188 Clinical Characteristics of Statin Management in a Co..:

Aldana, V. ; Vera, C.C. ; Jimenez, A....
Value in Health. 26 (2023) 6 - p. S50 , 2023

Link: https://doi.org/10.1016/..

6

HSD41 Healthcare Models for Rare Diseases: A Systematic Lit..:

Ossa, M.E. ; Londono, S. ; Rodriguez Ordonez, P.
Value in Health. 26 (2023) 12 - p. S301 , 2023

Link: https://doi.org/10.1016/..

7

HPR112 Systematic Review for Rare Diseases Policy: A Sight ..:

Perez, S. ; Upegui, A. ; Ossa, M.E..
Value in Health. 26 (2023) 6 - p. S231 , 2023

Link: https://doi.org/10.1016/..

8

EE403 Economic Analysis of Dupilumab Use in Patients With C..:

Upegui, A. ; Cadena, P. ; Patiño, G..
Value in Health. 26 (2023) 12 - p. S128 , 2023

Link: https://doi.org/10.1016/..

9

EE293 A Cost Analysis on Renal Disease Progression of Fabry..:

Londono, S. ; Ossa, M.E. ; Solano, D.A.
Value in Health. 26 (2023) 6 - p. S112 , 2023

Link: https://doi.org/10.1016/..

10

EE322 A Cost Analysis for Macrovascular Events, Comparison ..:

Londono, S. ; Garcia, W. ; Salamanca, C....
Value in Health. 26 (2023) 12 - p. S113 , 2023

Link: https://doi.org/10.1016/..

11

EE176 A Cost Analysis on Complications of Fabry Disease Pat..:

Londono, S. ; Ossa, M.E. ; Becerra, J..
Value in Health. 26 (2023) 6 - p. S91 , 2023

Link: https://doi.org/10.1016/..

12

EE57 Healthcare Costs Avoided in the Treatment of Acquired ..:

Londono, S. ; Gil-Rojas, Y. ; Lasalvia, P.
Value in Health. 26 (2023) 6 - p. S69 , 2023

Link: https://doi.org/10.1016/..

13

EE345 Clinical and Economic Impact Analysis of Viscosupplem..:

Vásquez, E. ; Lasalvia, P. ; Upegui, A....
Value in Health. 26 (2023) 12 - p. S117 , 2023

Link: https://doi.org/10.1016/..

14

HTA87 Caplacizumab for the Treatment of Acquired Thrombotic..:

Soto, J. ; Gomez, L.M. ; Lasalvia, P....
Value in Health. 26 (2023) 6 - p. S274 , 2023

Link: https://doi.org/10.1016/..

15

HSD57 Adherence Teleassistance-Based Program Impact in a Re..:

Mejia-Torres, S. ; Camacho-Misol, C. ; Londono, S....
Value in Health. 26 (2023) 12 - p. S304 , 2023

Link: https://doi.org/10.1016/..